Recent news highlights Lifevantage's dividend activity, quarterly earnings challenges, and ongoing business initiatives including marketing campaigns and patent grants.

• Lifevantage issued an ex-dividend reminder for June 1, 2026, indicating ongoing dividend payments to shareholders [N1].
• The company reported that Q3 2026 earnings and revenues did not meet expectations, reflecting operational challenges [N2].
• The Q3 2026 earnings transcript provides detailed management commentary on financial results and business conditions [N3].
• Lifevantage's Q2 2026 earnings transcript and report indicated revenues and earnings lagging expectations [N6][N7].

Lifevantage has demonstrated profitability with positive net income and earnings per share in the latest fiscal year. The company maintains liquidity with a current ratio near 1.9 and a cash ratio of 1.0, supporting operational stability. Its stock repurchase program and dividend payments indicate a commitment to shareholder returns. Product innovation, including patented nutritional supplements, and marketing initiatives may support business growth and brand recognition.

Recent quarterly earnings reports indicate challenges in meeting revenue and earnings expectations, which may reflect operational or market pressures. The lack of detailed disclosure on sector, industry, and geographic markets limits transparency. Potential risks disclosed in SEC filings could materially affect financial condition and results. The company's stock repurchase program and dividend payments may constrain cash resources if operational performance weakens.

Lifevantage's moat appears to be linked to its proprietary nutritional supplement products, including patented formulations, and its marketing campaigns targeting health-conscious consumers. The company's ability to maintain liquidity and return capital to shareholders through dividends and stock repurchases may support investor confidence. However, the absence of detailed sector and industry classification and limited public disclosure on competitive advantages constrain a full assessment of its moat.

• Market and Operational Risks: Risk factors disclosed in SEC filings highlight potential material impacts on business operations, financial condition, and results of operations. These risks include market competition, regulatory changes, and operational challenges [S1][S2].
• Financial Performance Risks: Recent quarterly earnings reports show difficulties in meeting revenue and earnings targets, which may affect future financial stability and investor confidence [N2][N7].
• Liquidity and Capital Allocation Risks: While liquidity ratios are currently stable, ongoing stock repurchases and dividend payments require careful capital management to avoid liquidity strain [S2][N1].

• Lifevantage Corp is a publicly traded company with ticker LFVN.
• The company filed its latest annual report (10-K) on August 27, 2026, covering the fiscal year ended June 30, 2026 [S1].
• Lifevantage reported net income of $5.072 million and basic and diluted earnings per share of $0.40 for the fiscal year ended June 30, 2026 [S1].
• As of June 30, 2026, Lifevantage had current assets of $38.297 million and current liabilities of $20.227 million, resulting in a current ratio of 1.89 and a cash ratio of 1.00 [S1].
• Cash and cash equivalents were $20.201 million as of June 30, 2025 [S1].
• The company has an active stock repurchase program authorized up to $60 million through December 31, 2027, with repurchases occurring in early 2026 [S2].
• Lifevantage's recent quarterly earnings reports indicate challenges in meeting revenue and earnings expectations in Q2 and Q3 2026 [N2][N3][N6][N7].
• The company paid quarterly dividends, with an ex-dividend date reminder issued for June 1, 2026 [N1].
• Lifevantage's business activities include launching marketing campaigns and obtaining patents for nutritional supplements, indicating a focus on health and wellness products [N1][N2].
• Risk factors disclosed in the 10-K and 10-Q filings highlight potential material impacts on business, financial condition, and results of operations, with no material changes reported recently [S1][S2].